Drugs / Normal Saline Flush, 0.9% Injectable Solution
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03755700 Comparator | Nov 2018 → Dec 2019 | acute coronary syndrome, coronary artery disorder | Rajaie Cardiovascular Medical and Research Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Normal Saline Flush, 0.9% Injectable Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03755700 ↗ |
| Route | Intravenous | “Normal saline 0.9% infusions (1 mL/kg) for 12 hours prior to and after coronary catheterization” NCT03755700 ↗ |